Black Rock Inc. Milestone Pharmaceuticals Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIST
# of Institutions
43Shares Held
30.2MCall Options Held
32.8KPut Options Held
0-
Rtw Investments, LP New York, NY3.26MShares$4.69 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$3.96 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$3.83 Million1.58% of portfolio
-
Lion Point Capital, LP New York, NY2.34MShares$3.37 Million6.61% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.15MShares$3.09 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $43.2M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...